e-learning
resources
Vienna 2009
Monday, 14.09.2009
New treatment and outcome measures for pulmonary rehabilitation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Osteoporosis and arterial stiffness in COPD: the CIROCO study
E. F. M. Wouters, M. Groenen, M. Boorsma, P. Rugman, J. Op‘t Rood, M. A. Spruit (Horn, Maastricht, Netherlands; London, United Kingdom)
Source:
Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Session:
New treatment and outcome measures for pulmonary rehabilitation
Session type:
E-Communication Session
Number:
1721
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. F. M. Wouters, M. Groenen, M. Boorsma, P. Rugman, J. Op‘t Rood, M. A. Spruit (Horn, Maastricht, Netherlands; London, United Kingdom). Osteoporosis and arterial stiffness in COPD: the CIROCO study. Eur Respir J 2009; 34: Suppl. 53, 1721
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
BOCSKEI Csaba - 14.09.2009 11:01
Csaba Bocskei MD. Ph.D.
It is wery interesting. Could yuo send the poster by mail to me? Thanks, Csaba csbocskei@gmail.com
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Arterial stiffness in patients with COPD: The CIROCO study
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010
Arterial stiffness in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Effects of pulmonary rehabilitation in COPD patients with increased baseline arterial stiffness: The CIROCO study
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010
Effects of pulmonary rehabilitation (PR) on arterial stiffness in patients with COPD: The CIROCO study
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
Central vascular pressure measurements during exercise in COPD: How to handle the respirophasic changes?
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Arterial stiffness in patients with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 552s
Year: 2007
Pulmonary function is associated with pulmonary artery systolic pressure in the general population: The Rotterdam study
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Arterial stiffness in patients with different severity of COPD
Source: Annual Congress 2010 - New diagnostic approaches in respiratory function
Year: 2010
24-hour arterial stiffness monitoring values in patients with COPD
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Changes in arterial stiffness during COPD exacerbations
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Arterial stiffness and endothelial dysfunction in stable COPD patients
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Peripheral arterial disease: an underestimated aetiology of exercise limitation in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 19s
Year: 2007
Pulmonary artery to aorta ratio and mortality risk in the general population: The Rotterdam study
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
Atorvastatin in Pulmonary Arterial Hypertension (APATH) study
Source: Eur Respir J 2012; 40: 67-74
Year: 2012
Function tests during research of arterial stiffness in COPD patients
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
Arterial stiffness measurements in COPD: Reliability over time
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study
Source: Eur Respir J 2016; 48: 787-796
Year: 2016
An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept